-

USDA New Proposed Rule On BioEngineered (GMO) Food Disclosure, Q1 2022 Webinar - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "USDA New Proposed Rule On BioEngineered (GMO) Food Disclosure" webinar has been added to ResearchAndMarkets.com's offering.

After attending this webinar, you will know what food products are impacted by the new rule, and what food products are exempt.

You will learn how to be fully compliant with the USDA Final Rule on Bioengineered Food Disclosure. It is essential that food professionals understand which foods the USDA has listed as bioengineered and what firms are exempt from the Bioengineered Disclosure Rule.

You will also be able to correctly label bioengineered/GMO (Genetically Modified) foods and non-GMO foods. Understanding the timelines for compliance is essential to ensuring your organization complies with the final rule in time to avoid regulatory enforcement actions.

Areas Covered in the Webinar:

  • Review list of bioengineered foods
  • Understand who is exempt from the bioengineered disclosure rule
  • Incidental additivities
  • Disclosure requirements in product labeling
  • Disclosure options available to food manufacturers and distributors
  • Symbols that are to be used and graphic requirements
  • Electronic or digital link disclosure
  • Small food manufacturers
  • Timelines for bioengineered food disclosure standard compliance

Who Should Attend:

  • Regulatory Affairs
  • Marketing managers
  • Product Manager
  • Labeling managers

For more information about this webinar visit https://www.researchandmarkets.com/r/8r97xt

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Blockchain and Non-Fungible Tokens new Technologies and the Relevant Law Training Course: Core Principles, Smart Contracts, NFTs, and Decentralized Finance Explained (Online Event: May 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Blockchain and Non-Fungible Tokens: Understanding new Technologies and the Relevant Law Training Course (May 20, 2026)" training has been added to ResearchAndMarkets.com's offering. Blockchain is a new technology that could potentially have major impacts in a wide range of industries. It has the potential to dramatically change how business is conducted - but there is no one central authority controlling blockchain, everyone has access to the same information. Are...

Writing Clinical Research with Integrity Training Course: Principles of Medical and Scientific Writing, Including Ethical Standards, Data Integrity, and Plagiarism Prevention (Online: Apr 20, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Writing Clinical Research with Integrity Training Course (Apr 20, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers key principles of medical and scientific writing, including ethical standards, data integrity, and plagiarism prevention. Participants will learn how to tailor content for various audiences, structure documents (e.g., manuscripts, protocols), and adhere to writing standards such as clarity, consistency, and correc...

In-Vitro Diagnostic Regulation (EU) 2017/746 Introduction Training Course (Online Event: Apr 16th - Apr 17th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (Apr 16th - Apr 17th, 2026)" training has been added to ResearchAndMarkets.com's offering. The In-Vitro Diagnostic Regulation (EU) 2017/746, which came into force in May 2017 with a transition period of five years, is intended to strengthen the current approval system for in-vitro diagnostics and makes substantial changes to the existing IVD Directive (98/79/EC) legislation. The Regulation in...
Back to Newsroom